| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner +3 more
10 companies
Fairmount Funds Management LLC is a Director, 10% Owner at GLTO with holdings across 10 companies. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $816.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | DNTH Dianthus Therapeutics, Inc. /de/ | Director, 10% Owner | Buy | 30,000 | $13.20 | $396,000.00 | +1.6% | -49.0% | +97.1% | |
| Sep 13, 2023 | DNTH Dianthus Therapeutics, Inc. /de/ | Director, 10% Owner | Buy | 24,254 | $11.20 | $271,679.87 | +0.7% | -37.5% | +122.3% | |
| Jul 13, 2023 | APGE Apogee Therapeutics, Inc. | Director | Buy | 2,941,176 | $17.00 | $49,999,992.00 | New | -4.1% | +126.2% | |
| Jun 9, 2023 | COGT Cogent Biosciences, Inc. | 10% Owner, See Remarks | Buy | 800,000 | $12.00 | $9,600,000.00 | +32.4% | +0.5% | -30.1% | |
| Aug 17, 2022 | VRDN Viridian Therapeutics, Inc.\de | Director, 10% Owner, See Remarks | Buy | 425,531 | $23.50 | $9,999,978.50 | +45.4% | +0.3% | -16.4% | |
| Jun 16, 2022 | COGT Cogent Biosciences, Inc. | 10% Owner, See Remarks | Buy | 1,200,000 | $8.25 | $9,900,000.00 | +94.3% | +116.4% | +55.6% | |
| Sep 21, 2021 | VRDN Viridian Therapeutics, Inc.\de | Director, 10% Owner | Buy | 909,000 | $11.00 | $9,999,000.00 | +3,109% | +57.8% | +64.5% |